[exclusive] 1 Blood Drop, High Fidelity Cancer Testing – Sanomics
Using a new generation of proprietary technologies, Sanomics offers blood-based genomics testing for cancer patients.
– Stanley Sy, Founder & CEO of Sanomics
– Irene N.Y. Chu, Director at KPMG Foundation – KPMG China
This is a collaboration between BeFast.TV, WHub and KPMG.
Sanomics is a pioneering genomics technology company based in Hong Kong. Using a new generation of proprietary technologies, Sanomics offers blood-based genomics testing for cancer patients. Genomics biomarker is essential to the personalized management of cancer. A classic example is the identification of epidermal growth factor receptor mutation (EGFR mut) as a biomarker for the use of EGFR targeted therapy for lung cancer patients. These oncogenic mutations occur in the tumor cell and genomics testing is routinely done in the tumor biopsy. However, feasibility and quality of biopsy are not always possible nor available. As an alternative, they are capable of detecting the abnormal mutation from plasma DNA. Presence of absence of the abnormal mutation will help the doctor to determine the treatment strategy.
WHub is the best way for startups to attract the resources they need such as; talent, investors, and collaboration. WHub spearheads many community programs with university collaboration including Job Fairs, Expert Panels and Startup Events. WHub is the Startup and Talent Platform in Hong Kong. With such a large audience and University connectivity, it goes beyond just a simple Job board or Startup Portfolio. WHub also offers transparent data to all startups concerning increased visibility and viability.
KPMG is a global network of professional services firms providing Audit, Tax and Advisory services. We operate in 154 countries and territories and have 200,000 people working in member firms around the world. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm is a legally distinct and separate entity and describes itself as such.